Petmed Express Inc (NASDAQ:PETS) retail pet pharmacy reported financial results for third quarter.
Earnings for the quarter surged 2.6% as the company posted decline in operating expenses. Revenue and earnings topped Wall Street’s expectations.
Company’s net income was $8.0 million, or $0.40 diluted per share, for the six months versus net income of $8.8 million, or $0.41 diluted per share, for same time period of previous year a 4.0% decrease to EPS.
Petmed Express Inc (NASDAQ:PETS) traded with volume of 1.11million shares in last session which was unexpectedly higher versus average trading capacity of 155,653.00 shares. The stock traded with opening bell at $11.00, gained the maximum price level of $11.62 and then finished the day at $11.15 by scoring +10.29%.
PETS remained successful in generating revenue of $233.63 million in the trailing twelve months and made net income of $15.77 million. The Company maintained a positive 6.75% for the net profit margin and in its operating margin it scored 10.56%. Company’s yearly revenue change for the last five years was 7.99%.
The PETS’s price to sales ratio is 0.97 and price to cash ratio is 3.36 for the past 12 months. As far as the returns from the company is concerned, return on assets remained as +16.27%.
The stock showed upbeat performance of +9.31% for the week which was maintained for the month at +13.43%. Likewise the positive performance for the trailing 3 months was recorded as +20.15% and in last year was +26.70% while the performance so far in current year remains at +11.95%.
Disclaimer
Fast Moving Stock does not own any shares or plan to get a position(s) in the company(s) anytime soon. Moreover, we have not been compensated for the posting of this article/report/analysis, as this is just an opinion of our writer/contributor. Not recommandation to buy or sell any stocks Read full
